These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23801879)

  • 41. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function].
    Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-reactive protein levels in stable COPD patients: a case-control study.
    Silva DR; Gazzana MB; Knorst MM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2.
    Kluve-Beckerman B; Yamada T; Hardwick J; Liepnieks JJ; Benson MD
    Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):663-9. PubMed ID: 9065791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRP and SAA1 Haplotypes Are Associated with Both C-Reactive Protein and Serum Amyloid A Levels: Role of Suppression Effects.
    Ko YL; Hsu LA; Wu S; Teng MS; Chou HH
    Mediators Inflamm; 2016; 2016():5830361. PubMed ID: 27313400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of small heat-shock protein αB-crystalline (HspB5) in COPD pathogenesis.
    Cherneva RV; Georgiev OB; Petrova DS; Trifonova NL; Stamenova M; Ivanova V; Vlasov VI
    Int J Chron Obstruct Pulmon Dis; 2012; 7():633-40. PubMed ID: 23055712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform.
    Mori M; Tiang G; Higuchi K
    Amyloid; 2014 Mar; 21(1):1-8. PubMed ID: 24228751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
    Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients.
    Lazovic B
    Med Arch; 2012; 66(3):159-60. PubMed ID: 22822613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased levels of inflammatory biomarker CX3CL1 in patients with chronic obstructive pulmonary disease.
    Hao W; Li M; Zhang C; Zhang Y; Du W
    Cytokine; 2020 Feb; 126():154881. PubMed ID: 31629111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant.
    Rau B; Steinbach G; Baumgart K; Gansauge F; Grünert A; Beger HG
    Crit Care Med; 2000 Mar; 28(3):736-42. PubMed ID: 10752823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between periodontal disease and chronic obstructive pulmonary disease: a case control study.
    Öztekin G; Baser U; Kucukcoskun M; Tanrikulu-Kucuk S; Ademoglu E; Isik G; Ozkan G; Yalcin F; Kiyan E
    COPD; 2014 Aug; 11(4):424-30. PubMed ID: 24378084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera.
    Sung HJ; Jeon SA; Ahn JM; Seul KJ; Kim JY; Lee JY; Yoo JS; Lee SY; Kim H; Cho JY
    J Proteomics; 2012 Apr; 75(7):2170-80. PubMed ID: 22300576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations.
    Karadeniz G; Polat G; Senol G; Buyuksirin M
    Inflammation; 2013 Aug; 36(4):948-53. PubMed ID: 23547018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific networks of plasma acute phase reactants are associated with the severity of chronic obstructive pulmonary disease: a case-control study.
    Arellano-Orden E; Calero-Acuña C; Cordero JA; Abad-Arranz M; Sánchez-López V; Márquez-Martín E; Ortega-Ruiz F; López-Campos JL
    Int J Med Sci; 2017; 14(1):67-74. PubMed ID: 28138311
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.
    Bu XL; Cao GQ; Shen LL; Xiang Y; Jiao SS; Liu YH; Zhu C; Zeng F; Wang QH; Wang YR; He Y; Zhou HD; Wang YJ
    Neurotox Res; 2015 Nov; 28(4):346-51. PubMed ID: 26243505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2).
    Steel DM; Sellar GC; Uhlar CM; Simon S; DeBeer FC; Whitehead AS
    Genomics; 1993 May; 16(2):447-54. PubMed ID: 7686132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
    Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
    Aliagas E; Muñoz-Esquerre M; Cuevas E; Careta O; Huertas D; López-Sánchez M; Escobar I; Dorca J; Santos S
    Respir Res; 2018 May; 19(1):103. PubMed ID: 29807526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.